Exp Clin Endocrinol Diabetes 2015; 123(07): 419-422
DOI: 10.1055/s-0035-1545344
Article
© Georg Thieme Verlag KG Stuttgart · New York

Type 1 Diabetes Mellitus and Exercise in Competitive Athletes

Autoren

  • I. Ratjen

    1   Osnabrück University of Applied Sciences, Osnabrück, Germany
    2   Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Institute for Diabetes Research, Düsseldorf, Germany
    3   German Center for Diabetes Research, Partner Düsseldorf, Germany
  • K. S. Weber

    2   Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Institute for Diabetes Research, Düsseldorf, Germany
    3   German Center for Diabetes Research, Partner Düsseldorf, Germany
  • M. Roden

    2   Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Institute for Diabetes Research, Düsseldorf, Germany
    3   German Center for Diabetes Research, Partner Düsseldorf, Germany
    4   Department of Endocrinology and Diabetology, University Hospital, Düsseldorf, Germany
  • M.-E. Herrmann

    1   Osnabrück University of Applied Sciences, Osnabrück, Germany
  • K. Müssig

    2   Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Institute for Diabetes Research, Düsseldorf, Germany
    3   German Center for Diabetes Research, Partner Düsseldorf, Germany
    4   Department of Endocrinology and Diabetology, University Hospital, Düsseldorf, Germany
Weitere Informationen

Publikationsverlauf

received 27. November 2014
first decision 15. Januar 2015

accepted 04. Februar 2015

Publikationsdatum:
08. April 2015 (online)

Abstract

Aims: The number of patients with type 1 diabetes mellitus who are actively participating in competitive sports is increasing. Here, we aimed to assess individual experiences of competitive athletes with type 1 diabetes and to compare these experiences with current recommendations.

Methods: A survey of 20 competitive athletes with type 1 diabetes, categorized as endurance (n=10) and non-endurance (n=10) athletes, was performed.

Results: Endurance and non-endurance athletes did not differ in gender distribution, age, body mass index, and known diabetes duration. Self-reported target blood glucose values prior to exercise were lower in non-endurance than in endurance athletes (195±34 vs. 137±28 mg/dl, P=0.001). The majority of all athletes experienced activity-induced hypo- and hyperglycemic events, independently of exercise type. However, endurance athletes used additional carbohydrate units to prevent activity-induced hypoglycemic events more frequently without monitoring their blood glucose levels than non-endurance athletes (50% vs. 0%, P=0.01). The reduction of the insulin dose on training and competition days compared to days without exercise was similar for endurance and non-endurance athletes.

Conclusion: These results point to a very individual adaption of the athlete’s therapy during training and competition. However, there are distinct differences in diabetes management between endurance and non-endurance athletes.